Archive October 2023

All of the articles archived for the month that you have specified are displayed below.

PUBLICATION ALERT: AURORA Trial Published: Key Step Toward Expanded Use of Cardiac PET

The results of the AURORA (International Study to Evaluate Diagnostic Efficacy of Flurpiridaz [18F] Injection PET MPI in the Detection of Coronary Artery Disease [CAD]) trial were published Oct. 9, in the Journal of the American College of Cardiology. The authors, led by Jamshid Maddahi, MD, FASNC, reported that PET imaging with flurpiridaz significantly exceeded prespecified threshold criteria for detection of CAD and was superior to Tc-labeled SPECT myocardial perfusion imaging for detection of CAD in the overall population and in women and obese patients. 


Read More

ASNC President Announces Advocacy Win: Evicore Expands Coverage of PET Myocardial Blood Flow

Speaking at ASNC2023's Opening Plenary Session, Mouaz H. Al-Mallah, MD, MSc, MASNC, announced an advocacy win that speaks to ASNC's perseverance. For more than two years, ASNC leaders have been talking with Evicore about expanding their coverage policy to include PET myocardial blood flow (MBF). 

"As of now, Evicore no longer considers myocardial blood flow experimental," Dr. Al-Mallah announced. "This is an important success for ASNC and, more importantly, for patient care." 


Read More